PROKIDNEY CORP. — Director's Dealing 2025

Feb 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2025-02-04

Reporting Person: Pereira Brian JG (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-04	Class A Ordinary Shares	C	81928	—	Acquired	81928	Direct
2025-02-04	Class A Ordinary Shares	C	675234	—	Acquired	675234	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-04	Class B Ordinary Shares	$0	C	81928	Disposed		Class A Ordinary Shares (81928)	Direct
2025-02-04	Common Units in ProKidney LP	$0	C	81928	Disposed		Class A Ordinary Shares (81928)	Direct
2025-02-04	Class B Ordinary Shares	$0	C	675234	Disposed		Class A Ordinary Shares (675234)	Indirect
2025-02-04	Common Units in ProKidney LP	$0	C	675234	Disposed		Class A Ordinary Shares (675234)	Indirect

Footnotes

F1: The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis.

F2: The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.

F3: The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.